Please assess the completion status of the following clinical trial:

Trial Title: Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Must have BMI \>=30 kg/m2 and \<50 kg/m2 at screening or BMI \>=27 kg/m2 and \<50 kg/m2 at screening in the presence of a comorbidity of hypertension and/or dyslipidemia~* Must have stable weight, ie, change of \< =5% in the 3 months before screening~* Must agree to utilize a highly effective method of birth control~Exclusion Criteria:~* An established diagnosis of diabetes mellitus~* Has a history of obesity with a known secondary cause (eg, Cushing's disease/syndrome)~* Has a history of hereditary glucose-galactose malabsorption or primary renal glycosuria~* Myocardial infarction, unstable angina, revascularization procedure, or cerebrovascular accident within 12 weeks before screening~* Has an Glycated hemoglobin (HBA1c) greater than or equal (\>=) to 65 percent~* An average of 3 seated blood pressure (BP) readings of systolic BP \>= 160 mm Hg and/or Diastolic BP \>= 100 millimeters of mercury at screening

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Canagliflozin + Phentermine (Type: EXPERIMENTAL): 300 mg capsule of Canagliflozin along with 15 mg capsule of Phentermine, taken once daily, orally for 26 weeks.
- Canagliflozin + Placebo (Phentermine) (Type: EXPERIMENTAL): 300 mg capsule of Canagliflozin along with matching placebo to Phentermine, taken once daily, orally for 26 weeks.
- Phentermine + Placebo (Canagliflozin) (Type: EXPERIMENTAL): 15 mg capsule of Phentermine along with matching placebo to Canagliflozin, taken once daily, orally for 26 weeks.
- Placebo (Type: PLACEBO_COMPARATOR): Matching placebo to Canagliflozin and Phentermine, taken once daily, orally for 26 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).